SlideShare a Scribd company logo
1 of 37
Age, co-morbidity and frailty


   Theo Wiggers
Barbara van Leeuwen
       Cascais, Portugal
   Sunday February 13th,2011




      Department of Surgery, University Medical Center Groningen
Introduction   Comorbidity   Frailty   Conclusion



                        This lecture


               •Introduction
               •Co morbidity/ disability
               •Frailty
               •Conclusions
Introduction   Comorbidity   Frailty   Conclusion

                 Ageing in The Netherlands
Introduction   Comorbidity   Frailty   Conclusion

                     Life expectancy


                       ♀



                               ♂


                                                    Walter LC, JAMA 2001
Introduction   Comorbidity   Frailty   Conclusion
                More cancers in the elderly




                                          Quaglia et al Int J Cancer 2007
Introduction   Comorbidity   Frailty   Conclusion

        The impact of cancer in an ageing world




                                                    WHO data 2007
Introduction   Comorbidity   Frailty   Conclusion

     1-and 6 mortality after rectal cancer surgery




                                         Rutten et al Lancet Oncolgy 2008
Introduction   Comorbidity   Frailty    Conclusion

                   Age and complications




                                       Janssen-Heijnen Eur J Cancer 2007
Introduction   Comorbidity   Frailty   Conclusion

          No improvement in survival for elderly




                                         Rutten et al Eur J Cancer 2007
Introduction   Comorbidity     Frailty   Conclusion

                       Cognitive decline


                                           Mild        Alzheimer's
                    Normal ageing
                                           cognitive   disease
                                           decline




                                                         Small et al., 2008
Introduction   Comorbidity   Frailty    Conclusion


           Post Operative Cognitive dysfunction

                 1064 Patients neuropsychological tests
                 before ,at discharge and after three months




                                                      Monk et al., 2008
Introduction   Comorbidity   Frailty   Conclusion


                      Mortality and POCD




                                                    Monk et al., 2008
Introduction   Comorbidity   Frailty      Conclusion


     Life time risk of non communicable disease
                (heart, diabetes, stroke)




                                       From: ageing and life course WHO 2001
Introduction   Comorbidity   Frailty    Conclusion


       Comorbidity and rectal cancer treatment




                                       Janssen-Heijnen Eur J Cancer 2007
Introduction   Comorbidity    Frailty     Conclusion


                             Disability



 • Inability to perform
   everyday task
   independently
Introduction   Comorbidity          Frailty          Conclusion




                  Disability:                     Comorbidity
                   ≥ 1ADL

                                  21,5%
                         5,7%

                                          46,2%

                                 26,6%

                                Frailty




                                                     Fried et al J Gerontol A Biol Sci 2004
Introduction   Comorbidity   Frailty   Conclusion
Introduction   Comorbidity   Frailty   Conclusion


                             Frailty


 • Vulnerability associated with age
 • Individual measurement of the
   severity and speed of the aging
   process associated with chronic
   illness and functional loss
 • Predictive of outcome?
Introduction   Comorbidity     Frailty   Conclusion




                             Identifying frail elderly
Introduction   Comorbidity   Frailty   Conclusion


         Estimating frailty in the surgical patient



 •   Predict postoperative morbidity/mortality
 •   Prevent functional decline
 •   Need for screening tool
 •   Few studies
Introduction        Comorbidity         Frailty            Conclusion

                         Identifying frail elderly
                                                                     CGA: comprehensive
                                                                     geriatric assessment:
                                                                   combination of tests used
                                                                  by geriatricians to estimate
                                                                  general wellbeing/ frailty in
                                                                   elderly patients. Too time
                                                                  consuming ( takes 2 hours
                                                                    on average) for surgical
                               what tools to use?                 practice and not specifically
                                                                     tested with regards to
                  PACE was initiated to develop a                      predictive value for
               screening tool for frailty in the elderly                  postoperative
                  surgical population. It consists of                    complications.
               several tests that are easy to use and
               measure different aspects of wellbeing
                   and frailty. This is the first study
                 measuring the predictive value of
                these tests in a surgical population.
Introduction   Comorbidity   Frailty   Conclusion

                    Identifying frail elderly



    • Preoperative Assessment of Cancer in the
      Elderly (PACE)
    • Estimating frailty in surgical elderly cancer
      patients (GFI)
Introduction   Comorbidity   Frailty   Conclusion


                             PACE
 • MMS (abnormal <24): Mini Mental State examination
 • ADL (dependent >0) Activities of Daily Life : things like
   going to toilet, eating a meal
 • IADL( dependent <8) Instrumental Activities of Daily Life :
   things like handling finances, making telephone call, taking
   medication
 • GDS (depressed >4) Geriatric Depression Scale; 15
   questions investigating mood
 • BFI (mod/severe fatigue >3) : Brief Fatigue Inventory
 • ASA (abnormal >1)
 • PS (abnormal >1) Performance Status
 • Satariano’s Index (1) : score for different sorts of co
   morbidity
Introduction      Comorbidity            Frailty      Conclusion


               PACE and hospital stay
           Component of PACE                            RR*          95%CI
           MMS abnormal (<24)                           1.18       0.76-1.86

           ADL dependent (>0)                           2.01       1.37-2.93

           IADL dependent (<8)                          1.58        1.11-2.24

           GDS depressed (>4)                           1.30       0.91-1.85

           BFI mod/severe fatigue (>3)                  1.29       0.90-1.84

           ASA abnormal (>1)                            0.85       0.60-1.20

           PS abnormal (>1)                             1.64       1.06-2.56

           Satariano’s Index (1)                        1.23       0.85-1.78
           Satariano’s Index (2+)                       1.36       0.70-2.65




                                                   Audisio et al. Crit Rev Oncol/Hem, 2008
Introduction   Comorbidity         Frailty      Conclusion


                  PACE and complications
               Component of PACE               Any complication

                                                RR*       95% CI

               MMS abnormal (<24)               1.23     0.81-1.88

               ADL dependent (>0)               1.41     0.95-2.10

               IADL dependent (<8) 47015146 1.43         1.03-1.98

               GDS depressed (>4)               1.30     0.93-1.81

               BFI mod/severe fatigue (>3)      1.52     1.09-2.12

               ASA abnormal (>1)                1.00     0.73-1.38

               PS abnormal (>1)                 1.64     1.07-2.52

               Satariano’s Index (1)            1.11     0.78-1.59
               Satariano’s Index (2+)           1.58     0.88-2.85



                                             Audisio et al. Crit Rev Oncol/Hem, 2008
Introduction    Comorbidity   Frailty   Conclusion


               Groningen Frailty Index (GFI)

    •   15 questions
    •   Predicts morbidity
    •   Easy to administer
    •   GFI ≥3 is frail
    •   30% of patients >65 yrs are frail
Introduction   Comorbidity   Frailty   Conclusion


                               GFI
    Mobility
    Physical fitness
    Vision
    Hearing
    Nutrition
    Co-morbidity
    Cognition
    Psychosocial
Introduction   Comorbidity   Frailty   Conclusion


                               GFI
    Mobility
    Can the patient perform the following tasks without
      assistance from another person (walking aids
      such as a cane or wheelchair are allowed)
    1. Grocery shopping                      YES/NO
    2. Walk outside house (around house
       or to neighbours)                     YES/NO
    3. Getting (un)dressed                   YES/NO
    4. Visiting restroom                     YES/NO
Introduction   Comorbidity   Frailty   Conclusion


                               GFI

    Hearing
    7. Does the patient encounter problems in daily life
      because of impaired hearing?
               YES/NO

    Nutrition
    8. Has the patient unintentionally lost a lot of
      weight in the past 6 months (6kg in 6 months or
      3 kg in a month)            YES/NO
Introduction   Comorbidity   Frailty   Conclusion

                                 GFI
   Psychosocial
   11. Does the patient ever experience emptiness
     around him?                              YES/NO
   12. Does the patient ever miss the presence
       of other people around him?            YES/NO
   13. Does the patient ever feel left alone?
                                              YES/NO
   14. Has the patient been feeling down or
     depressed lately?                        YES/NO
   15. Has the patient felt nervous or anxious lately?
                                              YES/NO
Introduction   Comorbidity   Frailty      Conclusion



                             GFI
     • Currently used in national study

     • To be tested in international setting started end 2008

     • Results expected in coming years
Introduction   Comorbidity   Frailty   Conclusion



                Perioperative care
Introduction      Comorbidity           Frailty         Conclusion



                               LIFE study
   •   Multicenter prospective randomized clinical trial
   •   Patients over 65 years surgery for a solid tumor
   •   Groningen Frailty Indicator ≥ 3
   •   Geriatric team preoperatively and monitored during hospital stay
   •   Primary outcome: incidence of delirium
   •   Secondary outcome
        – Return to the pre-operative living situation within 3 months postoperatively
        – The Physical and Mental Component Summary measures of the SF-36
        – Complications during hospital stay including mortality
        – Care Dependency Scale at discharge
        – Percentage of patients receiving adjuvant treatment
        – Direct health care and non-health care costs during hospital stay

   • Power/data analysis: incidence of delirium 30%
     expected reduction of 15 % sample sizes of 2x133
Introduction   Comorbidity   Frailty    Conclusion



                         LIFE study
   • Incidence of postoperative delirium was lower as
     expected
   • Less delirium in the intervention group
   • Co morbidity, activities in daily life, abdominal surgical
     procedure are major determinants in the incidence of
     delirium
Introduction   Comorbidity   Frailty   Conclusion


                         Conclusion
   • The increase in postoperative morbidity an
     mortality is a result of comorbidity, disability and
     frailty and most likely not due to the biological
     behavior of the cancer
   • Estimating frailty in elderly cancer patient of
     increasing importance
   • Search for ideal screening tool predictive of
     outcome ongoing
   • Need for tailor made treatment
   • Future: tailor made intervention to prevent
     postoperative morbidity
Introduction   Comorbidity   Frailty   Conclusion


               Co morbidity, disability, frailty


               Prevent over- and undertreatment




                 Patient tailored treatment
MCC 2011 - Slide 5

More Related Content

What's hot

Preventing Stroke in Carotid Stenosis
Preventing Stroke in Carotid StenosisPreventing Stroke in Carotid Stenosis
Preventing Stroke in Carotid StenosisDr.Mahmoud Abbas
 
Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...neurologia segura
 
Modifiable factors for urinary incontinence - type cause and effect poster
Modifiable factors for urinary incontinence - type cause and effect posterModifiable factors for urinary incontinence - type cause and effect poster
Modifiable factors for urinary incontinence - type cause and effect posterMichelle Lai
 
Friday 1745 – benamer cto and diabetes
Friday 1745 – benamer   cto and diabetesFriday 1745 – benamer   cto and diabetes
Friday 1745 – benamer cto and diabetesEuro CTO Club
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.cardiositeindia
 
Can brain atrophy measurement help us in monitoring MS progression in routine...
Can brain atrophy measurement help us in monitoring MS progression in routine...Can brain atrophy measurement help us in monitoring MS progression in routine...
Can brain atrophy measurement help us in monitoring MS progression in routine...MS Trust
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2ifa2012
 
ACC 2013 what did we learn
ACC 2013 what did we learnACC 2013 what did we learn
ACC 2013 what did we learnhospital
 
Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finaldwestenberger
 
Dr Rollin Gallagher Presn to Can Pain Summit 042412
Dr Rollin Gallagher Presn to Can Pain Summit 042412Dr Rollin Gallagher Presn to Can Pain Summit 042412
Dr Rollin Gallagher Presn to Can Pain Summit 042412Canadian Pain Summit 2012
 
Quality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoQuality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoKimberly Schafer
 
Spine Lecture tandem spinal stenosis 2019
Spine Lecture tandem spinal stenosis 2019Spine Lecture tandem spinal stenosis 2019
Spine Lecture tandem spinal stenosis 2019Spiro Antoniades
 
Zura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyZura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyGrant Steen
 
1 vte and kit education for healthcare professionals and administrators
1 vte and kit education for healthcare professionals and administrators1 vte and kit education for healthcare professionals and administrators
1 vte and kit education for healthcare professionals and administratorsvtesimplified
 

What's hot (20)

Preventing Stroke in Carotid Stenosis
Preventing Stroke in Carotid StenosisPreventing Stroke in Carotid Stenosis
Preventing Stroke in Carotid Stenosis
 
Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...Efficacy and safety of microvascular decompression for trigeminal in patients...
Efficacy and safety of microvascular decompression for trigeminal in patients...
 
Modifiable factors for urinary incontinence - type cause and effect poster
Modifiable factors for urinary incontinence - type cause and effect posterModifiable factors for urinary incontinence - type cause and effect poster
Modifiable factors for urinary incontinence - type cause and effect poster
 
Friday 1745 – benamer cto and diabetes
Friday 1745 – benamer   cto and diabetesFriday 1745 – benamer   cto and diabetes
Friday 1745 – benamer cto and diabetes
 
Valgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradialValgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradial
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
Can brain atrophy measurement help us in monitoring MS progression in routine...
Can brain atrophy measurement help us in monitoring MS progression in routine...Can brain atrophy measurement help us in monitoring MS progression in routine...
Can brain atrophy measurement help us in monitoring MS progression in routine...
 
ADH
ADHADH
ADH
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2
 
ACC 2013 what did we learn
ACC 2013 what did we learnACC 2013 what did we learn
ACC 2013 what did we learn
 
Malignancy by Dr Eamon Raith
Malignancy by Dr Eamon RaithMalignancy by Dr Eamon Raith
Malignancy by Dr Eamon Raith
 
Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -final
 
Dr Rollin Gallagher Presn to Can Pain Summit 042412
Dr Rollin Gallagher Presn to Can Pain Summit 042412Dr Rollin Gallagher Presn to Can Pain Summit 042412
Dr Rollin Gallagher Presn to Can Pain Summit 042412
 
Quality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in MexicoQuality of life in HIV-positive persons in Mexico
Quality of life in HIV-positive persons in Mexico
 
IWO bijeenkomst - 22 april Prof. Lems
IWO bijeenkomst - 22 april Prof. LemsIWO bijeenkomst - 22 april Prof. Lems
IWO bijeenkomst - 22 april Prof. Lems
 
Spine Lecture tandem spinal stenosis 2019
Spine Lecture tandem spinal stenosis 2019Spine Lecture tandem spinal stenosis 2019
Spine Lecture tandem spinal stenosis 2019
 
Zura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyZura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-Epidemiology
 
Aversano
AversanoAversano
Aversano
 
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
Saito S DRAGON trial
 
1 vte and kit education for healthcare professionals and administrators
1 vte and kit education for healthcare professionals and administrators1 vte and kit education for healthcare professionals and administrators
1 vte and kit education for healthcare professionals and administrators
 

Similar to MCC 2011 - Slide 5

CT coronary angiography in ED chest pain patients
CT coronary angiography in ED chest pain patientsCT coronary angiography in ED chest pain patients
CT coronary angiography in ED chest pain patientskellyam18
 
癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿Kit Leong
 
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...European School of Oncology
 
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Gianfranco Tammaro
 
The new treatment paradigm for MS
The new treatment paradigm for MSThe new treatment paradigm for MS
The new treatment paradigm for MSMS Trust
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenEurasian Federation of Oncology
 
NSEMS May 2015 summary
NSEMS May 2015 summaryNSEMS May 2015 summary
NSEMS May 2015 summaryBecki Knight
 
Which Chest Pain Can Be Safely Discharged From Ed
Which Chest Pain Can Be Safely Discharged From EdWhich Chest Pain Can Be Safely Discharged From Ed
Which Chest Pain Can Be Safely Discharged From EdRashidi Ahmad
 
Radiation induced Rectal morbidity
Radiation induced Rectal morbidityRadiation induced Rectal morbidity
Radiation induced Rectal morbidityDebarshi Lahiri
 
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anzianoIl trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anzianoMerqurio
 
Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...njsargent
 
Delirium (Charmaine Berggreen)
Delirium (Charmaine Berggreen)Delirium (Charmaine Berggreen)
Delirium (Charmaine Berggreen)honorhealth
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simba Takuva
 
Uterine anomalies and reproductive outcomes
Uterine anomalies and reproductive outcomesUterine anomalies and reproductive outcomes
Uterine anomalies and reproductive outcomesWaled Ayad
 
LifeVest/ Roger Carrillo&Juan D. Garisto
LifeVest/ Roger Carrillo&Juan D. GaristoLifeVest/ Roger Carrillo&Juan D. Garisto
LifeVest/ Roger Carrillo&Juan D. GaristoJuan D. Garisto, MD
 
The Changing Face of Trauma Care
The Changing Face of Trauma Care The Changing Face of Trauma Care
The Changing Face of Trauma Care Camilla Wong
 

Similar to MCC 2011 - Slide 5 (20)

CT coronary angiography in ED chest pain patients
CT coronary angiography in ED chest pain patientsCT coronary angiography in ED chest pain patients
CT coronary angiography in ED chest pain patients
 
癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿
 
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...
MON 2011 - Slide 17 - L. Repetto - Spotlight session - Cancer in the older pe...
 
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
 
The new treatment paradigm for MS
The new treatment paradigm for MSThe new treatment paradigm for MS
The new treatment paradigm for MS
 
Oncologic emergencies
Oncologic emergenciesOncologic emergencies
Oncologic emergencies
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
 
NSEMS May 2015 summary
NSEMS May 2015 summaryNSEMS May 2015 summary
NSEMS May 2015 summary
 
Which Chest Pain Can Be Safely Discharged From Ed
Which Chest Pain Can Be Safely Discharged From EdWhich Chest Pain Can Be Safely Discharged From Ed
Which Chest Pain Can Be Safely Discharged From Ed
 
Radiation induced Rectal morbidity
Radiation induced Rectal morbidityRadiation induced Rectal morbidity
Radiation induced Rectal morbidity
 
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anzianoIl trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
Il trattamento del carcinoma glottico in stadio iniziale nel paziente anziano
 
Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...
 
Delirium (Charmaine Berggreen)
Delirium (Charmaine Berggreen)Delirium (Charmaine Berggreen)
Delirium (Charmaine Berggreen)
 
1 Hassan
1  Hassan1  Hassan
1 Hassan
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
Uterine anomalies and reproductive outcomes
Uterine anomalies and reproductive outcomesUterine anomalies and reproductive outcomes
Uterine anomalies and reproductive outcomes
 
Inflammation Persists Even During HIV Therapy
Inflammation Persists Even During HIV TherapyInflammation Persists Even During HIV Therapy
Inflammation Persists Even During HIV Therapy
 
Palliative care beyond cancer
Palliative care beyond cancerPalliative care beyond cancer
Palliative care beyond cancer
 
LifeVest/ Roger Carrillo&Juan D. Garisto
LifeVest/ Roger Carrillo&Juan D. GaristoLifeVest/ Roger Carrillo&Juan D. Garisto
LifeVest/ Roger Carrillo&Juan D. Garisto
 
The Changing Face of Trauma Care
The Changing Face of Trauma Care The Changing Face of Trauma Care
The Changing Face of Trauma Care
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

Recently uploaded

Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...narwatsonia7
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girlsnehamumbai
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Nehru place Escorts
 
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Nehru place Escorts
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Miss joya
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 

Recently uploaded (20)

Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
 
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
Russian Call Girls in Chennai Pallavi 9907093804 Independent Call Girls Servi...
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 

MCC 2011 - Slide 5

  • 1. Age, co-morbidity and frailty Theo Wiggers Barbara van Leeuwen Cascais, Portugal Sunday February 13th,2011 Department of Surgery, University Medical Center Groningen
  • 2. Introduction Comorbidity Frailty Conclusion This lecture •Introduction •Co morbidity/ disability •Frailty •Conclusions
  • 3. Introduction Comorbidity Frailty Conclusion Ageing in The Netherlands
  • 4. Introduction Comorbidity Frailty Conclusion Life expectancy ♀ ♂ Walter LC, JAMA 2001
  • 5. Introduction Comorbidity Frailty Conclusion More cancers in the elderly Quaglia et al Int J Cancer 2007
  • 6. Introduction Comorbidity Frailty Conclusion The impact of cancer in an ageing world WHO data 2007
  • 7. Introduction Comorbidity Frailty Conclusion 1-and 6 mortality after rectal cancer surgery Rutten et al Lancet Oncolgy 2008
  • 8. Introduction Comorbidity Frailty Conclusion Age and complications Janssen-Heijnen Eur J Cancer 2007
  • 9. Introduction Comorbidity Frailty Conclusion No improvement in survival for elderly Rutten et al Eur J Cancer 2007
  • 10. Introduction Comorbidity Frailty Conclusion Cognitive decline Mild Alzheimer's Normal ageing cognitive disease decline Small et al., 2008
  • 11. Introduction Comorbidity Frailty Conclusion Post Operative Cognitive dysfunction 1064 Patients neuropsychological tests before ,at discharge and after three months Monk et al., 2008
  • 12. Introduction Comorbidity Frailty Conclusion Mortality and POCD Monk et al., 2008
  • 13. Introduction Comorbidity Frailty Conclusion Life time risk of non communicable disease (heart, diabetes, stroke) From: ageing and life course WHO 2001
  • 14. Introduction Comorbidity Frailty Conclusion Comorbidity and rectal cancer treatment Janssen-Heijnen Eur J Cancer 2007
  • 15. Introduction Comorbidity Frailty Conclusion Disability • Inability to perform everyday task independently
  • 16. Introduction Comorbidity Frailty Conclusion Disability: Comorbidity ≥ 1ADL 21,5% 5,7% 46,2% 26,6% Frailty Fried et al J Gerontol A Biol Sci 2004
  • 17. Introduction Comorbidity Frailty Conclusion
  • 18. Introduction Comorbidity Frailty Conclusion Frailty • Vulnerability associated with age • Individual measurement of the severity and speed of the aging process associated with chronic illness and functional loss • Predictive of outcome?
  • 19. Introduction Comorbidity Frailty Conclusion Identifying frail elderly
  • 20. Introduction Comorbidity Frailty Conclusion Estimating frailty in the surgical patient • Predict postoperative morbidity/mortality • Prevent functional decline • Need for screening tool • Few studies
  • 21. Introduction Comorbidity Frailty Conclusion Identifying frail elderly CGA: comprehensive geriatric assessment: combination of tests used by geriatricians to estimate general wellbeing/ frailty in elderly patients. Too time consuming ( takes 2 hours on average) for surgical what tools to use? practice and not specifically tested with regards to PACE was initiated to develop a predictive value for screening tool for frailty in the elderly postoperative surgical population. It consists of complications. several tests that are easy to use and measure different aspects of wellbeing and frailty. This is the first study measuring the predictive value of these tests in a surgical population.
  • 22. Introduction Comorbidity Frailty Conclusion Identifying frail elderly • Preoperative Assessment of Cancer in the Elderly (PACE) • Estimating frailty in surgical elderly cancer patients (GFI)
  • 23. Introduction Comorbidity Frailty Conclusion PACE • MMS (abnormal <24): Mini Mental State examination • ADL (dependent >0) Activities of Daily Life : things like going to toilet, eating a meal • IADL( dependent <8) Instrumental Activities of Daily Life : things like handling finances, making telephone call, taking medication • GDS (depressed >4) Geriatric Depression Scale; 15 questions investigating mood • BFI (mod/severe fatigue >3) : Brief Fatigue Inventory • ASA (abnormal >1) • PS (abnormal >1) Performance Status • Satariano’s Index (1) : score for different sorts of co morbidity
  • 24. Introduction Comorbidity Frailty Conclusion PACE and hospital stay Component of PACE RR* 95%CI MMS abnormal (<24) 1.18 0.76-1.86 ADL dependent (>0) 2.01 1.37-2.93 IADL dependent (<8) 1.58 1.11-2.24 GDS depressed (>4) 1.30 0.91-1.85 BFI mod/severe fatigue (>3) 1.29 0.90-1.84 ASA abnormal (>1) 0.85 0.60-1.20 PS abnormal (>1) 1.64 1.06-2.56 Satariano’s Index (1) 1.23 0.85-1.78 Satariano’s Index (2+) 1.36 0.70-2.65 Audisio et al. Crit Rev Oncol/Hem, 2008
  • 25. Introduction Comorbidity Frailty Conclusion PACE and complications Component of PACE Any complication RR* 95% CI MMS abnormal (<24) 1.23 0.81-1.88 ADL dependent (>0) 1.41 0.95-2.10 IADL dependent (<8) 47015146 1.43 1.03-1.98 GDS depressed (>4) 1.30 0.93-1.81 BFI mod/severe fatigue (>3) 1.52 1.09-2.12 ASA abnormal (>1) 1.00 0.73-1.38 PS abnormal (>1) 1.64 1.07-2.52 Satariano’s Index (1) 1.11 0.78-1.59 Satariano’s Index (2+) 1.58 0.88-2.85 Audisio et al. Crit Rev Oncol/Hem, 2008
  • 26. Introduction Comorbidity Frailty Conclusion Groningen Frailty Index (GFI) • 15 questions • Predicts morbidity • Easy to administer • GFI ≥3 is frail • 30% of patients >65 yrs are frail
  • 27. Introduction Comorbidity Frailty Conclusion GFI Mobility Physical fitness Vision Hearing Nutrition Co-morbidity Cognition Psychosocial
  • 28. Introduction Comorbidity Frailty Conclusion GFI Mobility Can the patient perform the following tasks without assistance from another person (walking aids such as a cane or wheelchair are allowed) 1. Grocery shopping YES/NO 2. Walk outside house (around house or to neighbours) YES/NO 3. Getting (un)dressed YES/NO 4. Visiting restroom YES/NO
  • 29. Introduction Comorbidity Frailty Conclusion GFI Hearing 7. Does the patient encounter problems in daily life because of impaired hearing? YES/NO Nutrition 8. Has the patient unintentionally lost a lot of weight in the past 6 months (6kg in 6 months or 3 kg in a month) YES/NO
  • 30. Introduction Comorbidity Frailty Conclusion GFI Psychosocial 11. Does the patient ever experience emptiness around him? YES/NO 12. Does the patient ever miss the presence of other people around him? YES/NO 13. Does the patient ever feel left alone? YES/NO 14. Has the patient been feeling down or depressed lately? YES/NO 15. Has the patient felt nervous or anxious lately? YES/NO
  • 31. Introduction Comorbidity Frailty Conclusion GFI • Currently used in national study • To be tested in international setting started end 2008 • Results expected in coming years
  • 32. Introduction Comorbidity Frailty Conclusion Perioperative care
  • 33. Introduction Comorbidity Frailty Conclusion LIFE study • Multicenter prospective randomized clinical trial • Patients over 65 years surgery for a solid tumor • Groningen Frailty Indicator ≥ 3 • Geriatric team preoperatively and monitored during hospital stay • Primary outcome: incidence of delirium • Secondary outcome – Return to the pre-operative living situation within 3 months postoperatively – The Physical and Mental Component Summary measures of the SF-36 – Complications during hospital stay including mortality – Care Dependency Scale at discharge – Percentage of patients receiving adjuvant treatment – Direct health care and non-health care costs during hospital stay • Power/data analysis: incidence of delirium 30% expected reduction of 15 % sample sizes of 2x133
  • 34. Introduction Comorbidity Frailty Conclusion LIFE study • Incidence of postoperative delirium was lower as expected • Less delirium in the intervention group • Co morbidity, activities in daily life, abdominal surgical procedure are major determinants in the incidence of delirium
  • 35. Introduction Comorbidity Frailty Conclusion Conclusion • The increase in postoperative morbidity an mortality is a result of comorbidity, disability and frailty and most likely not due to the biological behavior of the cancer • Estimating frailty in elderly cancer patient of increasing importance • Search for ideal screening tool predictive of outcome ongoing • Need for tailor made treatment • Future: tailor made intervention to prevent postoperative morbidity
  • 36. Introduction Comorbidity Frailty Conclusion Co morbidity, disability, frailty Prevent over- and undertreatment Patient tailored treatment